Indrayani Biotech reports consolidated net profit of Rs 1.61 crore in the March 2022 quarter

Sales rise 140.92% to Rs 17.25 crore

Net profit of Indrayani Biotech reported to Rs 1.61 crore in the quarter ended March 2022 as against net loss of Rs 3.25 crore during the previous quarter ended March 2021. Sales rose 140.92% to Rs 17.25 crore in the quarter ended March 2022 as against Rs 7.16 crore during the previous quarter ended March 2021.

For the full year,net profit reported to Rs 4.44 crore in the year ended March 2022 as against net loss of Rs 11.21 crore during the previous year ended March 2021. Sales rose 191.94% to Rs 61.57 crore in the year ended March 2022 as against Rs 21.09 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales17.257.16 141 61.5721.09 192 OPM %12.93-7.96 -11.00-23.47 - PBDT1.80-1.43 LP 5.11-6.65 LP PBT1.62-1.24 LP 4.45-7.10 LP NP1.61-3.25 LP 4.44-11.21 LP

Powered by Capital Market - Live News